Relevant and even prescient commentary on news, politics and the economy.

Drug price control in the Inflation Reduction Act

Inflation Reduction Act The Inflation Reduction Act drug price negotiation is small in returns, low in the number of drugs initially impacted, and slow to start. Ten drugs will be selected and the impact of the act begins in 2026. It rises to 20 drugs to be negotiated in 2029. The new act ignores European […]

U.S. Seeks to Block Bankruptcy Plan That Would Free Sacklers From Opioid Claims

“The Justice Department moved on Thursday to block a bankruptcy plan that grants broad legal immunity to the pharmaceutical company Purdue Pharma, whose drug OxyContin has been at the heart of the nation’s opioid epidemic. William K. Harrington, the U.S. trustee for the Justice Department, filed a motion in federal court to halt confirmation of […]

Vaccine Progress

Guest Author at Angry Bear is Professor Joel Eissenberg. Dr. Joel Eissenberg is a professor of Biochemistry and Molecular Biology and is probably a good source to ask questions concerning pandemics and bringing new vaccines to market. Ask questions  .  .   .  I am sure he will answer the same as he has commented in […]

A Look at Drug Pricing 2020, Costs, and Why – “Redux”

I had written on the high cost of pharmaceuticals late 2019, “Another Look at Drug Pricing, Costs, and Why” citing from the World Health Organization, the ICER, JAMA Network, Health Affairs, and my own posts (links below and in text). You will find the some of the same articles cited in new commentary of increased […]